BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19307452)

  • 1. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.
    Pieper GM; Ionova IA; Cooley BC; Migrino RQ; Khanna AK; Whitsett J; Vásquez-Vivar J
    J Pharmacol Exp Ther; 2009 Jun; 329(3):890-9. PubMed ID: 19307452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity.
    Pieper GM; Nilakantan V; Halligan NL; Khanna AK; Hilton G; Vásquez-Vivar J
    Biochem J; 2005 Nov; 391(Pt 3):541-7. PubMed ID: 16000090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes.
    Ionova IA; Vásquez-Vivar J; Whitsett J; Herrnreiter A; Medhora M; Cooley BC; Pieper GM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2178-87. PubMed ID: 18835915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection.
    Ionova IA; Vásquez-Vivar J; Cooley BC; Khanna AK; Whitsett J; Herrnreiter A; Migrino RQ; Ge ZD; Regner KR; Channon KM; Alp NJ; Pieper GM
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H88-96. PubMed ID: 20418482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection.
    Cai B; Roy DK; Sciacca R; Michler RE; Cannon PJ
    Int J Cardiol; 1995 Jul; 50(3):243-51. PubMed ID: 8537148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection.
    Pieper GM; Halligan NL; Hilton G; Konorev EA; Felix CC; Roza AM; Adams MB; Griffith OW
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3125-30. PubMed ID: 12624190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase.
    Nilakantan V; Halligan NL; Nguyen TK; Hilton G; Khanna AK; Roza AM; Johnson CP; Adams MB; Griffith OW; Pieper GM
    J Heart Lung Transplant; 2005 Oct; 24(10):1591-9. PubMed ID: 16210135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
    Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical change in antioxidant enzyme gene expression and activity in acute cardiac rejection: role of inducible nitric oxide synthase.
    Nilakantan V; Zhou X; Hilton G; Roza AM; Adams MB; Johnson CP; Pieper GM
    Mol Cell Biochem; 2005 Feb; 270(1-2):39-47. PubMed ID: 15792352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of COX-2 during cardiac allograft rejection.
    Yang X; Ma N; Szabolcs MJ; Zhong J; Athan E; Sciacca RR; Michler RE; Anderson GD; Wiese JF; Leahy KM; Gregory S; Cannon PJ
    Circulation; 2000 Feb; 101(4):430-8. PubMed ID: 10653836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.
    Pieper GM; Nilakantan V; Chen M; Zhou J; Khanna AK; Henderson JD; Johnson CP; Roza AM; Szabó C
    J Pharmacol Exp Ther; 2005 Jul; 314(1):53-60. PubMed ID: 15784653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNI-1493 prolongs survival and reduces myocyte loss, apoptosis, and inflammation during rat cardiac allograft rejection.
    Yang X; Szabolcs M; Minanov O; Ma N; Sciacca RR; Bianchi M; Tracey KJ; Michler RE; Cannon PJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):146-55. PubMed ID: 9676735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection.
    Szabolcs MJ; Sun J; Ma N; Albala A; Sciacca RR; Philips GB; Parkinson J; Edwards N; Cannon PJ
    Circulation; 2002 Oct; 106(18):2392-6. PubMed ID: 12403672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
    Pieper GM; Nilakantan V; Zhou X; Khanna AK; Johnson CP; Roza AM; Adams MB; Hilton G; Felix CC
    J Pharmacol Exp Ther; 2005 Feb; 312(2):774-9. PubMed ID: 15347735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase.
    Szabolcs M; Michler RE; Yang X; Aji W; Roy D; Athan E; Sciacca RR; Minanov OP; Cannon PJ
    Circulation; 1996 Oct; 94(7):1665-73. PubMed ID: 8840859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats.
    An J; Du J; Wei N; Xu H; Pritchard KA; Shi Y
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1783-91. PubMed ID: 19717731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergence in regulation of nitric-oxide synthase and its cofactor tetrahydrobiopterin by tumor necrosis factor-alpha. Ceramide potentiates nitric oxide synthesis without affecting GTP cyclohydrolase I activity.
    Vann LR; Twitty S; Spiegel S; Milstien S
    J Biol Chem; 2000 May; 275(18):13275-81. PubMed ID: 10788433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of GTP cyclohydrolase I and inducible nitric oxide synthase mRNAs in mouse osteoblastic cells activated by proinflammatory cytokines.
    Togari A; Arai M; Mogi M; Kondo A; Nagatsu T
    FEBS Lett; 1998 May; 428(3):212-6. PubMed ID: 9654136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.